Evidence map›Paper›PMID 41632506›Full record

ArticleeLife2026

The chromatin remodeller CHD4 regulates transcription factor binding to both prevent activation of silent enhancers and maintain active regulatory elements.

Andria Koulle, Oluwaseun Ogundele, Devina Shah, India Baker, Maya Lopez, David Lando, Nicola Reynolds, Ramy Ragheb, Ernest D Laue, Brian Hendrich

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andria KoulleCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0009-0004-0321-2858
Oluwaseun OgundeleCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0003-1979-6101
Devina ShahCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0009-0004-1944-993X
India BakerCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-4787-6259
Maya LopezCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0009-0006-4806-1103
David LandoCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-5783-8769
Nicola ReynoldsCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0003-1620-2750
Ramy RaghebCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-5892-1767
Ernest D LaueCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-7476-4148
Brian HendrichCambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-0231-3073

Funding

Isaac Newton Trust 17.24(aa)Medical Research Council MR/M010082/1Medical Research Council MR/P019471/1Medical Research Council MR/X018342/1Medical Research Council MR/Y000595/1Wellcome 206291/Z/17/ZWellcome - MRC Cambridge Stem Cell Institute, University of Cambridge 203151/Z/16/ZWellcome Trust
6 · The paper itself

Abstract

Chromatin organisation and transcriptional regulation are tightly coordinated processes that are essential for maintaining cellular identity and function. ATP-dependent chromatin remodelling proteins play critical roles in control of genome structure and in regulating transcription across eukaryotes. Their essential nature, however, has made it difficult to define exactly how these functions are mediated. The chromatin remodeller CHD4 has been shown to be capable of sliding nucleosomes in vitro, and to regulate chromatin accessibility and gene expression in vivo. Using an inducible depletion system, here we identify a second mechanism of action for CHD4 in actively restricting the residence time of transcription factors (TFs) on chromatin. Together, these activities result in distinct, context-dependent outcomes: at highly accessible regulatory elements, CHD4 limits TF binding to maintain regulatory function, while at low-accessibility euchromatic regions, it prevents TF engagement and sustains chromatin compaction, thereby silencing cryptic enhancers. Collectively, these mechanisms enable CHD4 to reduce transcriptional noise while preserving the responsiveness of active regulatory networks.

Indexed as

Chromatin Assembly and DisassemblyEnhancer Elements, GeneticGene Expression RegulationMi-2 Nucleosome Remodeling and Deacetylase ComplexTranscription FactorsAnimalsChromatinDNA HelicasesMiceProtein BindingChromatinDNA HelicasesMi-2beta protein, mouseMi-2 Nucleosome Remodeling and Deacetylase ComplexTranscription Factorschromatinchromatin remodellingchromosomesembryonic stem cellenhancergene expressionmousenucleosometranscription factors

Identifiers

PMID41632506
PMCPMC12867480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.